Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6501)
All Articles published online
|
Publishing Process of This Article
|
Aug 26, 2021 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. World J Cardiol 2021; 13(8): 325-339 [PMID: 34589168 DOI: 10.4330/wjc.v13.i8.325] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v13/i8/325.htm |
| Number | Citing Articles |
| 1 |
Maya K. Jangid, Gaurav M. Doshi. Cross talk on therapeutic strategies: natriuretic peptides and inhibiting neprilysin in hypertension management. Hypertension Research 2024; doi: 10.1038/s41440-024-01989-w
|
| 2 |
Vasudeva Reddy Netala, Sireesh Kumar Teertam, Huizhen Li, Zhijun Zhang. A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies. Cells 2024; 13(17): 1471 doi: 10.3390/cells13171471
|
| 3 |
Samah S. Abbas, Mona F. Schaalan, Sahar M. Gebril, Fatma E. Hassan, Maha O. Mahmoud, Soha O. Hassanin. LCZ696 (sacubitril/valsartan) protects against cyclophosphamide-induced nephrotoxicity in adult male rats: Up-regulation of Apelin-13/ACE2, miR-200, and down-regulation of TGF-β/SMAD 2/3 and miR-192. Life Sciences 2022; 306: 120850 doi: 10.1016/j.lfs.2022.120850
|
| 4 |
Xiaoye Li, Chengchun Zuo, Can Chen, Dan Tian, Jing Li, Linlin Fan, Xiaoyu Li, Qianzhou Lv. Effectiveness and safety evaluation of sacubitril/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: A prospective cohort study. International Journal of Cardiology 2023; 371: 244 doi: 10.1016/j.ijcard.2022.09.050
|
| 5 |
Navya Sakhamuri, Sreekartthik Athiyaman, Bhawna Randhi, Sai Dheeraj Gutlapalli, Jingxiong Pu, Maheen F Zaidi, Maithily Patel, Lakshmi Malvika Atluri, Natalie A Gonzalez, Michael Alfonso. Sacubitril/Valsartan in Heart Failure Hospitalization: Two Pills a Day to Keep Hospitalizations Away?. Cureus 2023; doi: 10.7759/cureus.37335
|